SVS — Svas Biosana SpA Balance Sheet
0.000.00%
- €42.09m
- €70.69m
- €120.31m
- 81
- 94
- 76
- 98
Annual balance sheet for Svas Biosana SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 7.22 | 31.1 | 29.5 | 40 | 37.4 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 33.7 | 35.5 | 43.7 | 49.2 | 50.9 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 66.8 | 93.1 | 105 | 124 | 125 |
Net Property, Plant And Equipment | 25.8 | 25.6 | 26.2 | 26.8 | 27.1 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 108 | 136 | 146 | 166 | 166 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 49.1 | 49.6 | 57.2 | 64.7 | 62.2 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 80.4 | 84.9 | 91.7 | 107 | 103 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 27.7 | 51 | 54.5 | 59 | 62.8 |
Total Liabilities & Shareholders' Equity | 108 | 136 | 146 | 166 | 166 |
Total Common Shares Outstanding |